Trial Profile
A Prospective, Open-label, Observational study to evaluate the long-term safety and efficacy of stiripentol in patients with Dravet syndrome and ongoing seizures
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Jun 2018
Price :
$35
*
At a glance
- Drugs Stiripentol (Primary)
- Indications Myoclonic epilepsies
- Focus Adverse reactions; Therapeutic Use
- 06 Jun 2018 New trial record
- 01 Jun 2018 Results published in the Developmental Medicine and Child Neurology